Patents Assigned to ALSAR LTD PARTNERSHIP
  • FLECAINIDE COMBINATION AND CONTROLLED-RELEASE FORMULATIONS FOR TREATING HEART DISEASES
    Publication number: 20210161879
    Abstract: The invention relates to flecainide formulations and to methods of their administration. Specifically, the invention relates to combination formulations of a flecainide and a rate control agent for treating various heart diseases, and to controlled-release flecainide formulations, including such formulations in combination with rate control agents.
    Type: Application
    Filed: February 4, 2021
    Publication date: June 3, 2021
    Applicant: ALSAR LTD PARTNERSHIP
    Inventor: Robert FISHEL
  • COMPOSITIONS AND METHODS FOR SUSTAINED RELEASE OF FLECAINIDE
    Publication number: 20210145813
    Abstract: The invention relates generally to sustained release compositions. Specifically, the invention relates to biphasic and triphasic compositions and methods for controlling the release of a medication to treat a heart disease.
    Type: Application
    Filed: January 27, 2021
    Publication date: May 20, 2021
    Applicant: ALSAR LTD PARTNERSHIP
    Inventor: Robert FISHEL
  • COMPOSITIONS AND METHODS FOR SUSTAINED RELEASE OF FLECAINIDE
    Publication number: 20210030733
    Abstract: The invention relates generally to sustained release compositions. Specifically, the invention relates to biphasic and triphasic compositions and methods for controlling the release of a medication to treat a heart disease.
    Type: Application
    Filed: April 16, 2019
    Publication date: February 4, 2021
    Applicant: ALSAR LTD PARTNERSHIP
    Inventor: Robert FISHEL